Role of KCNQ channels in skeletal muscle arteries and periadventitial vascular dysfunction

Hypertension

Volumn 61, Issue 1, 2013, Pages 151-159

  Zavaritskaya, Olga ^a   Zhuravleva, Nadezda ^a,b,e   Schleifenbaum, Johanna ^b   Gloe, Torsten ^a   Devermann, Lena ^a   Kluge, Reinhart ^c   Mladenov, Mitko ^a,f   Frey, Manfred ^d   Gagov, Hristo ^a,g   Fésüs, Gabor ^b   Gollasch, Maik ^b   Schubert, Rudolf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

^f SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^g UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

adipocyte derived relaxing factor; KCNQ channels; obesity hypertension; vascular dysfunction

Indexed keywords

10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; ANTIHYPERTENSIVE AGENT; LINOPIRDINE; MESSENGER RNA; POTASSIUM CHANNEL KCNQ; POTASSIUM ION; RETIGABINE; SEROTONIN; UNCLASSIFIED DRUG; VASOACTIVE AGENT; VRX 0530727; VRX 0621238; VRX 0621688;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERY; ARTERY DILATATION; ARTERY RESISTANCE; ARTERY TONE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; GENE EXPRESSION PROFILING; GRACILIS MUSCLE; GRACILIS MUSCLE ARTERY; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE POTENTIAL; MOUSE; MYOGRAPHY; NONHUMAN; PATCH CLAMP; POLYMERASE CHAIN REACTION; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER; TELEMETRY;

ADIPOSE TISSUE; ANIMALS; ANTHRACENES; ARTERIAL PRESSURE; ARTERIES; INDOLES; ISOMETRIC CONTRACTION; KCNQ POTASSIUM CHANNELS; MALE; MEMBRANE POTENTIALS; MICE; MUSCLE, SKELETAL; POTASSIUM CHANNEL BLOCKERS; PYRIDINES; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 84871610085     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.197566     Document Type: Article

References (42)

1. Löhn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002;16:1057-1063. (Pubitemid 34753512)
2. Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, Gollasch M. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension. 2004;44:271-276. (Pubitemid 39167221)
3. Gollasch M, Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol Sci. 2004;25:647-653. (Pubitemid 39458171)
4. Dubrovska G, Verlohren S, Luft FC, Gollasch M. Mechanisms of ADRF release from rat aortic adventitial adipose tissue. Am J Physiol Heart Circ Physiol. 2004;286:H1107-H1113. (Pubitemid 38248627)
5. Gao YJ, Zeng ZH, Teoh K, Sharma AM, Abouzahr L, Cybulsky I, Lamy A, Semelhago L, Lee RM. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg. 2005;130:1130-1136. (Pubitemid 41427351)
6. Gálvez B, de Castro J, Herold D, Dubrovska G, Arribas S, González MC, Aranguez I, Luft FC, Ramos MP, Gollasch M, Fernández Alfonso MS. Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 2006;26:1297-1302.
7. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol. 2007;151:323-331. (Pubitemid 46842669)
8. Reifenberger MS, Turk JR, Newcomer SC, Booth FW, Laughlin MH. Perivascular fat alters reactivity of coronary artery: effects of diet and exercise. Med Sci Sports Exerc. 2007;39:2125-2134. (Pubitemid 350211504)
9. Gálvez-Prieto B, Dubrovska G, Cano MV, Delgado M, Aranguez I, González MC, Ruiz-Gayo M, Gollasch M, Fernández-Alfonso MS. A reduction in the amount and anti-contractile effect of periadventitial mes-enteric adipose tissue precedes hypertension development in spontaneously hypertensive rats. Hypertens Res. 2008;31:1415-1423.
10. Fésüs G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC, Gollasch M. Adiponectin is a novel humoral vasodilator. Cardiovasc Res. 2007;75:719-727. (Pubitemid 47243720)
11. Marchesi C, Ebrahimian T, Angulo O, Paradis P, Schiffrin EL. Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and infammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension. 2009;54:1384-1392.
12. Verlohren, S., Dubrovska, G., Luft, F. C., and Gollasch, M. Control of arterial tone by perivascular adipose tissue. Recent Res.Develop.Physiol. 2004;2:259-264.
13. Malinowski M, Deja MA, Gołba KS, Roleder T, Biernat J, Wos S. Perivascular tissue of internal thoracic artery releases potent nitric oxide and prostacyclin-independent anticontractile factor. Eur J Cardiothorac Surg. 2008;33:225-231.
14. Lee RM, Ding L, Lu C, Su LY, Gao YJ. Alteration of perivascular adipose tissue function in angiotensin II-induced hypertension. Can J Physiol Pharmacol. 2009;87:944-953.
15. Fang L, Zhao J, Chen Y, Ma T, Xu G, Tang C, Liu X, Geng B. Hydrogen sulfde derived from periadventitial adipose tissue is a vasodilator. J Hypertens. 2009;27:2174-2185.
16. Schleifenbaum J, Köhn C, Voblova N, Dubrovska G, Zavarirskaya O, Gloe T, Crean CS, Luft FC, Huang Y, Schubert R, Gollasch M. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sul-fde. J Hypertens. 2010;28:1875-1882.
17. Lee YC, Chang HH, Chiang CL, Liu CH, Yeh JI, Chen MF, Chen PY, Kuo JS, Lee TJ. Role of perivascular adipose tissue-derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension. Circulation. 2011;124:1160-1171.
18. Ohya S, Sergeant GP, Greenwood IA, Horowitz B. Molecular variants of KCNQ channels expressed in murine portal vein myocytes: a role in delayed rectifer current. Circ Res. 2003;92:1016-1023. (Pubitemid 36588501)
19. Yeung SY, Pucovský V, Moffatt JD, Saldanha L, Schwake M, Ohya S, Greenwood IA. Molecular expression and pharmacological identifcation of a role for K(v)7 channels in murine vascular reactivity. Br J Pharmacol. 2007;151:758-770. (Pubitemid 47075320)
20. Yeung SY, Lange W, Schwake M, Greenwood IA. Expression profle and characterisation of a truncated KCNQ5 splice variant. Biochem Biophys Res Commun. 2008;371:741-746.
21. Mackie AR, Brueggemann LI, Henderson KK, Shiels AJ, Cribbs LL, Scrogin KE, Byron KL. Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance. J Pharmacol Exp Ther. 2008;325:475-483. (Pubitemid 351574788)
22. Jepps TA, Chadha PS, Davis AJ, Harhun MI, Cockerill GW, Olesen SP, Hansen RS, Greenwood IA. Downregulation of Kv7.4 channel activity in primary and secondary hypertension. Circulation. 2011;124:602-611.
23. Chadha PS, Zunke F, Zhu HL, Davis AJ, Jepps TA, Olesen SP, Cole WC, Moffatt JD, Greenwood IA. Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired β-adrenoceptor-mediated relaxation of renal arteries in hypertension. Hypertension. 2012;59:877-884.
24. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26. (Pubitemid 8132079)
25. Pfaff MW, Horgan GW, Dempfe L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
26. Huckstorf C, Behm R, Habeck JO, Rückborn K, Franz U. Blood pressure, heart rate and arterial blood gas reactions to acute hypoxia in carotid body denervated spontaneously hypertensive rats. Biomed Biochim Acta. 1987;46:925-931.
27. Kurtz TW, Griffn KA, Bidani AK, Davisson RL, Hall JE; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: part 2: blood pressure measurement in experimental animals: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Arterioscler Thromb Vasc Biol. 2005;25:e22-e33.
28. Hercule HC, Schunck WH, Gross V, Seringer J, Leung FP, Weldon SM, da Costa Goncalves ACh, Huang Y, Luft FC, Gollasch M. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Arterioscler Thromb Vasc Biol. 2009;29:54-60.
29. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268(4 pt 1):C799-C822.
30. Greenwood IA, Ohya S. New tricks for old dogs: KCNQ expression and role in smooth muscle. Br J Pharmacol. 2009;156:1196-1203.
31. Hanner M, Schmalhofer WA, Green B, Bordallo C, Liu J, Slaughter RS, Kaczorowski GJ, Garcia ML. Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high affnity interaction. J Biol Chem. 1999;274:25237-25244.
32. Escoubas P, Diochot S, Célérier ML, Nakajima T, Lazdunski M. Novel tarantula toxins for subtypes of voltage-dependent potassium channels in the Kv2 and Kv4 subfamilies. Mol Pharmacol. 2002;62:48-57. (Pubitemid 34680515)
33. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local infammation and hypoxia abolish the protective anticon-tractile properties of perivascular fat in obese patients. Circulation. 2009;119:1661-1670.
34. Lee RM, Lu C, Su LY, Gao YJ. Endothelium-dependent relaxation factor released by perivascular adipose tissue. J Hypertens. 2009;27:782-790.
35. Gollasch M. Vasodilator signals from perivascular adipose tissue. Br J Pharmacol. 2012;165:633-642.
36. Petkova-Kirova P, Gagov H, Krien U, Duridanova D, Noack T, Schubert R. 4-aminopyridine affects rat arterial smooth muscle BK(Ca) currents by changing intracellular pH. Br J Pharmacol. 2000;131:1643-1650. (Pubitemid 32056430)
37. Mackie AR, Byron KL. Cardiovascular KCNQ (Kv7) potassium channels: physiological regulators and new targets for therapeutic intervention. Mol Pharmacol. 2008;74:1171-1179.
38. Zhong XZ, Harhun MI, Olesen SP, Ohya S, Moffatt JD, Cole WC, Greenwood IA. Participation of KCNQ (Kv7) potassium channels in myo-genic control of cerebral arterial diameter. J Physiol (Lond). 2010;588(Pt 17):3277-3293.
39. Albarwani S, Nemetz LT, Madden JA, Tobin AA, England SK, Pratt PF, Rusch NJ. Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels. J Physiol (Lond). 2003;551(Pt 3):751-763. (Pubitemid 37221070)
40. Amberg GC, Santana LF. Kv2 channels oppose myogenic constriction of rat cerebral arteries. Am J Physiol, Cell Physiol. 2006;291: C348-C356. (Pubitemid 44148158)
41. Brueggemann LI, Moran CJ, Barakat JA, Yeh JZ, Cribbs LL, Byron KL. Vasopressin stimulates action potential fring by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells. Am J Physiol Heart Circ Physiol. 2007;292:H1352-H1363. (Pubitemid 46377123)
42. Søgaard R, Ljungstrøm T, Pedersen KA, Olesen SP, Jensen BS. KCNQ4 channels expressed in mammalian cells: functional characteristics and pharmacology. Am J Physiol, Cell Physiol. 2001;280:C859-C866.